Ruiter D J, Bhan A K, Harrist T J, Sober A J, Mihm M C
J Immunol. 1982 Dec;129(6):2808-15.
The presence of major histocompatibility antigens in malignant melanoma and benign nevomelanocytic lesions and the nature of associated mononuclear inflammatory cells were studied in situ by using monoclonal antibodies and an immunoperoxidase technique. HLA-A,B,C (HLA) and beta 2-microglobulin (beta 2m) were found on malignant melanocytes in primary cutaneous and metastatic melanomas. In contrast, HLA antigens were not identified on nevomelanocytes in benign hyperplasia or nevocellular nevi, although in some cases faint staining for beta 2m was present. The staining of nevomelanocytes for HLA and beta 2 was variable in cases of nevomelanocytic dysplasia. The degree of mononuclear cellular response correlated with the expression of HLA (or beta 2m) on nevomelanocytes. Most of the inflammatory cells were identified as T cells. The majority of T cells were of helper/inducer phenotype, whereas a lesser number were phenotypically suppressor/cytotoxic T cells. The findings suggest that expression of HLA may be involved in triggering or eliciting a cellular immune response against dysplastic or malignant nevomelanocytes.
采用单克隆抗体和免疫过氧化物酶技术,对恶性黑色素瘤和良性痣细胞性病变中主要组织相容性抗原的存在情况以及相关单核炎性细胞的性质进行了原位研究。在原发性皮肤黑色素瘤和转移性黑色素瘤的恶性黑素细胞上发现了HLA - A、B、C(HLA)和β2 - 微球蛋白(β2m)。相比之下,在良性增生性痣或痣细胞痣的痣细胞上未发现HLA抗原,不过在某些情况下存在β2m的微弱染色。在痣细胞发育异常的病例中,痣细胞对HLA和β2的染色情况各不相同。单核细胞反应程度与痣细胞上HLA(或β2m)的表达相关。大多数炎性细胞被鉴定为T细胞。大多数T细胞为辅助/诱导表型,而表型为抑制/细胞毒性T细胞的数量较少。这些发现表明,HLA的表达可能参与触发或引发针对发育异常或恶性痣细胞的细胞免疫反应。